4DKL
Crystal structure of the mu-opioid receptor bound to a morphinan antagonist
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 23-ID-D |
Synchrotron site | APS |
Beamline | 23-ID-D |
Temperature [K] | 78 |
Detector technology | CCD |
Collection date | 2011-11-30 |
Detector | MARMOSAIC 300 mm CCD |
Wavelength(s) | 1.033 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 70.882, 174.730, 68.353 |
Unit cell angles | 90.00, 107.84, 90.00 |
Refinement procedure
Resolution | 30.488 - 2.800 |
R-factor | 0.2347 |
Rwork | 0.233 |
R-free | 0.27530 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3odu |
RMSD bond length | 0.005 |
RMSD bond angle | 0.928 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | PHENIX ((phenix.refine: 1.7.2_869)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 30.500 | 2.900 |
High resolution limit [Å] | 2.800 | 2.800 |
Rmerge | 0.144 | 0.788 |
Number of reflections | 19145 | |
<I/σ(I)> | 10.6 | 1.8 |
Completeness [%] | 99.0 | 99.3 |
Redundancy | 5.8 | 5.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | LIPIDIC CUBIC PHASE | 7 | 293 | 100 mM HEPES, pH 7.0, 300 mM lithium sulfate, 7.5% DMSO, 30-38% PEG400 in monoolein:cholesterol mixed in a 10:1 ratio, LIPIDIC CUBIC PHASE, temperature 293K |